Eurofins CDMO

Planegg, DE · San Diego, CA
Find alternatives to Eurofins CDMO for Biologics →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
81.6
Signal Score
✓ FDA Inspections (7) ○ Clinical Trials ○ SEC Filings ✓ Press (8) ○ EMA GMP ○ MHRA GMP

Quick Facts: Eurofins CDMO

Signal Score
81.6/100 (as of 2026-10-29)
Quality Compliance
100.0/100 — Bonus: 4 consecutive NAI inspections
Headquarters
Planegg, DE · San Diego, CA
Modalities
Biologics, Cell Therapy
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Eurofins CDMO

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
Bonus: 4 consecutive NAI inspections
Sources: FDA Data Dashboard
Bonus: 4 consecutive NAI inspections
FDA Inspections7 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2026-05-15)
Bonus: 4 consecutive NAI inspections
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesBiologics, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 68.0
Parent company: Eurofins Scientific
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Eurofins Scientific
Financial assessment: 68.0/100
Capacity 63.0
2 manufacturing sites
Sites: Planegg, DE, San Diego, CA
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
Press Signals8 articles (not scored)
2 manufacturing sites

Eurofins CDMO FDA Inspection History

2026-05
2025-12
2025-06
2025-03
2024-07
2023-06
2023-02
NAI VAI OAI
Date Site Type 483 citations posted Classification
2026-05-15
Eurofins Donor & Product Testing, Inc.
Honolulu, Hawaii Company-level
Human Cellular, Tissue, and Gene Therapies Not posted No Action Indicated (NAI)
2025-12-12
Eurofins Donor & Product Testing, LLC
Philadelphia, Pennsylvania Facility-linked
Human Cellular, Tissue, and Gene Therapies Not posted No Action Indicated (NAI)
2025-06-27
Eurofins Donor & Product Testing Inc.
Winston Salem, North Carolina Company-level
Human Cellular, Tissue, and Gene Therapies Not posted No Action Indicated (NAI)
2025-03-26
Eurofins Donor & Product Testing, LLC
Irwindale, California Facility-linked
Human Cellular, Tissue, and Gene Therapies Not posted No Action Indicated (NAI)
2024-07-19
Eurofins Donor & Product Testing LLC
Centennial, Colorado Facility-linked
Human Cellular, Tissue, and Gene Therapies Not posted Voluntary Action Indicated (VAI)
2023-06-09
Eurofins Donor & Product Testing, Inc.
Honolulu, Hawaii Company-level
Human Cellular, Tissue, and Gene Therapies Not posted No Action Indicated (NAI)
2023-02-17
Eurofins Donor & Product Testing, LLC
Philadelphia, Pennsylvania Facility-linked
Vaccines and Allergenic Products Not posted No Action Indicated (NAI)
Source: FDA Data Dashboard · Retrieved Nov 21, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data. This company's careers site asks automated readers not to collect it (robots.txt), and we respect that.
Source: smartrecruiters · Checked Nov 20, 2026

Company Signals 8 articles

Company announcements, not verified evidence. They do not change any score.
regulatory 2026-04-21
Dr. Kirithivasan Venkatesan Appointed as Senior Director – Process R&D at Eurofins CDMO India - hrtoday.in
Dr. Kirithivasan Venkatesan Appointed as Senior Director – Process R&D at Eurofins CDMO India  hrtoday.in
general 2026-04-17
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - BioSpace
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing  BioSpace
general 2026-04-16
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - Business Wire
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing  Business Wire
general 2026-04-16
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - Bluefield Daily Telegraph
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing  Bluefield Daily Telegraph
general 2026-04-16
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - Yahoo Finance
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing  Yahoo Finance
general 2026-03-10
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - The Manila Times
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study  The Manila Times
general 2026-03-10
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO ... - Caledonian Record
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO ...  Caledonian Record
general 2026-03-10
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - Bitget
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study  Bitget

Frequently Asked Questions About Eurofins CDMO

How many FDA inspections does Eurofins CDMO have on record?
CDMO Signal tracks 7 FDA inspections for Eurofins CDMO, sourced from the FDA inspection database. See the full inspection history above.
Has Eurofins CDMO received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Eurofins CDMO.
What is Eurofins CDMO's CDMO Signal Score?
Eurofins CDMO has a Signal Score of 82/100, based on quality, operations, financial stability, and capacity data.
Evaluating Eurofins CDMO for a manufacturing program?
Use the free AI matchmaker to compare Eurofins CDMO against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics CDMOs → Cell Therapy CDMOs →

Similar CDMOs

Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.9
mRNA, Biologics, Cell Therapy
ProBio
Pennington, NJ · Nanjing, CN
Signal Score: 64.0
mRNA, Biologics, CAR-T, Cell Therapy
Syngene International
Bengaluru, India
Signal Score: 80.3
Biologics, Cell Therapy
Singota Solutions
Bloomington, IN
Signal Score: 59.0
Cell Therapy, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 90.1
Biologics, mRNA, Small Molecule API, Oral Solid Dose, High-Potency APIs, Sterile Fill-Finish

Compare Eurofins CDMO with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Eurofins CDMO
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.